AltaCorp Capital Inc Analyst on Potential of Biosynthetic Cannabinoids

AltaCorp Capital Inc Research Analyst David M. Kideckel, PhD, MBA provides an update on AltaCorp’s operations and shares his thoughts on the emerging …

source